The Ontario Neurodegenerative Disease Research Initiative
Preprint
Abstract
Objective: In individuals over the age of 65, concomitant neurodegenerative pathologies contribute to cognitive and/or motor decline and can be aggravated by cerebrovascular disease, but our understanding of how these pathologies synergize to produce the decline represents an important knowledge gap. The Ontario Neurodegenerative Disease Research Initiative (ONDRI), a multi-site, longitudinal, observational cohort study, recruited participants across multiple prevalent neurodegenerative diseases and cerebrovascular disease, collecting a wide array of data and thus allowing for deep investigation into common and unique phenotypes. This paper describes baseline features of the ONDRI cohort, understanding of which is essential when conducting analyses or interpreting results. Methods: Five disease cohorts were recruited: Alzheimer’s disease/amnestic mild cognitive impairment (AD/MCI), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), Parkinson’s disease (PD), and cerebrovascular disease (CVD). Assessment platforms included clinical, neuropsychology, eye tracking, gait and balance, neuroimaging, retinal imaging, genomics, and pathology. We describe recruitment, data collection, and data curation protocols, and provide a summary of ONDRI baseline characteristics. Results: 520 participants were enrolled. Most participants were in the early stages of disease progression. Participants had a median age of 69 years, a median Montreal Cognitive Assessment score of 25, a median percent of independence of 100 for basic activities of daily living, and a median of 93 for instrumental activities. Variation between disease cohorts existed for age, level of cognition, and geographic location. Conclusion: ONDRI data will enable exploration into unique and shared pathological mechanisms contributing to cognitive and motor decline across the spectrum of neurodegenerative diseases.Keywords
This publication has 39 references indexed in Scilit:
- APOE ε4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementiaNeurology, 2019
- Cerebral degeneration in amyotrophic lateral sclerosisNeurology Clinical Practice, 2019
- The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohortAnnals of Clinical and Translational Neurology, 2018
- A broader view of dementia: multiple co-pathologies are the normBrain, 2018
- Burden of neurological conditions in CanadaNeuroToxicology, 2017
- The Ontario Neurodegenerative Disease Research Initiative (ONDRI)Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2016
- Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysisThe Lancet Neurology, 2015
- Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegenerationThe Lancet Neurology, 2013
- Alzheimer's Disease Neuroimaging Initiative (ADNI)Neurology, 2010
- Mixed brain pathologies account for most dementia cases in community-dwelling older personsNeurology, 2007